Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
- PMID: 32824645
- PMCID: PMC7551055
- DOI: 10.3390/antib9030043
Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
Abstract
Anaphylaxis secondary to thymoglobulin (anti-thymocyte globulin) is a rare condition that can be life threatening. Thymoglobulin is a rabbit-derived T-cell depleting polyclonal immunoglobulin. It is commonly used for induction immunosuppression and/or for treatment of acute rejection in renal transplantation. We report a case of a living kidney transplant recipient who developed intraoperative anaphylactic shock secondary to thymoglobulin. The patient had a history of pet rabbit exposure. This case report highlights the importance of prompt identification and management of intraoperative anaphylaxis, which is key to a successful outcome. Induction immunosuppression selection based on patient characteristics is important. Communication between the anesthesia team and surgeons played a key role in stopping the donor surgery.
Keywords: anaphylactic shock; living donor kidney transplantation; rabbit anti-thymocyte globulin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Thymoglobulin (Anti-Thymocyte Globulin [Rabbit]) Package Insert. Genzyme Corporation; Cambridge, MA, USA: 2018.
-
- Kandil E., Alabbas H., Distant D. Anaphylaxis to thymoglobulin: A case report and literature review. J. La. State Med. Soc. 2009;161:279–281. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
